Biotech Archives - Page 786 of 795

2 minute read

FDA
News

Neuronetics Announces TMS Coverage Policies To Expand Patient Access To NeuroStar TMS Therapy For Mental Health

July 11, 4:47 PM

Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in

STIM

5 minute read

FDA
News

GSK Prepares Us For 2022-23 Flu Season With Over 50M Influenza Vaccine Doses

By Benzinga Newsdesk

July 11, 3:27 PM

GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses GSK begins shipping FLULAVAL QUADRIVALENT and FLUARIX QUADRIVALENT GSK plc (NYSE:GSK) today announced it has started shipping doses of

GSK

1 minute read

Iterum Therapeutics Shares Are Surging – Read Why

By Vandana Singh

July 11, 2:31 PM

Iterum Therapeutics plc (NASDAQ:ITRM) has agreed with the FDA under the special protocol assessment (SPA) process on the design, endpoints, and…

ITRM

1 minute read

Needham Previews Neurocrine’s Upcoming Mid-Stage Data from Essential Tremor Study

By Vandana Singh

July 11, 2:20 PM

Needham previews the upcoming Phase 2 data readout for Neurocrine Biosciences Inc's (NASDAQ: NBIX) NBI-827104, a t-type calcium channel blocker in essential tremor (ET), by mid-2022.

JAZZ

1 minute read

Why NuCana Shares Are Rising Today?

By Vandana Singh

July 11, 1:36 PM

Regional Court of Dusseldorf has ruled in favor of NuCana plc (NASDAQ:NCNA), stating that Gilead Sciences Ireland UC and Gilead Sciences GmbH…

GILD

1 minute read

Molecular Diagnostics To Be Granted US Patent titled ‘METHODS FOR SUBTYPING DIFFUSE LARGE B-CELL LYMPHOMA (AND USING THE RESULTS FOR DIAGNOSIS, PROGNOSIS, AND THERAPY SELECTION)’

By Bill Haddad

July 11, 1:29 PM

https://twitter.com/PatentGrants/status/1546546503556014080

HTGM

1 minute read

With New Phase 3 Data From Its Hemophilia Study, Novo Nordisk Plots Route To FDA

By Vandana Singh

July 11, 1:24 PM

Novo Nordisk A/S (NYSE:NVO) announced the phase 3 results of the explorer7 study, assessing the efficacy and safety of prophylactic treatment…

NVO

1 minute read

Novo Nordisk’s Mim8 Shows Potential As Once Monthly Treatment For Hemophilia A

By Vandana Singh

July 11, 12:52 PM

Novo Nordisk A/S (NYSE:NVO) announced that the phase 1 & 2 FRONTIER1 dose-escalation study in treating people with hemophilia…

NVO

1 minute read

Aethlon Medical Secures FDA Clearance For Amendment In Initial-Stage COVID-19 Study

By Ragothaman Srinivasan

July 11, 11:41 AM

The U.S. Food and Drug Administration (FDA) has approved an amendment to the protocol of the ongoing clinical trial investigating Aethlon Medical’s (NASDAQ: AEMD) lead therapy Aethlon Hemopurifier for patients with severe COVID-19.

AEMD